Ascendis Pharma A/S (ASND)
$251.95-0.53%Close
SELLRECOVERY · day 3
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $15.6B
- Avg volume
- 694.5K
- Beta
- 0.38
- P/E (TTM)
- 17.84
- Short % float
- 5.53%
- Days to cover
- 7.2
- SI change
- +9.7%
- 1W
- +1.84%
- 1M
- -0.75%
- 3M
- +1.98%
- YTD
- +18.13%
- vs SPY 1W
- +3.03%
- vs SPY 1M
- -4.07%
- vs SPY 3M
- -0.41%
- vs SPY YTD
- +6.37%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- SEMSELLSelect Medical Holdings CorporationBULLQ 9$16.51-0.12%
- KRYSSELLKrystal Biotech, Inc.RECOVERYQ 47$341.72-1.40%
- DGXBUYQuest Diagnostics IncorporatedBULLQ 23$243.87-0.21%
- BMRNBUYBioMarin Pharmaceutical Inc.BULLQ 12$65.07-2.44%
- RPRXBUYRoyalty Pharma plcBULLQ 12$61.33+0.03%
- AVAHBUYAveanna Healthcare Holdings Inc.BULLQ 15$13.71+4.18%
- TRLVBUYRECOVERYQ 14$11.14+0.36%
- ITGRBUYInteger Holdings CorporationBULLQ 19$125.07-0.10%
- NVSTBUYEnvista Holdings CorpBEARQ 3$27.34+0.51%
- MDLNSELLMedline Inc.Q -11$34.70+1.28%
- CAIBUYCaris Life Sciences, Inc.RECOVERYQ 0$26.13-0.53%
- ENLVSELLEnlivex Therapeutics Ltd.CRISISQ -20$1.51+2.72%
Industry peers
FMP comparable companies · ranked by market cap
- MRNABUYModerna, Inc.$55.1BRECOVERYQ 29$138.89-4.30%
- RVMDBUYRevolution Medicines, Inc.$45.0BBULLQ 31$211.58+1.01%
- ROIVBUYRoivant Sciences Ltd.$26.3BBULLQ 31$36.36+0.17%
- GHBUYGuardant Health, Inc.$21.9BBULLQ 23$163.18-4.40%
- BBIOSELLBridgeBio Pharma, Inc.$15.9BRECOVERYQ 20$81.07-0.53%
- EXELSELLExelixis, Inc.$13.7BBEARQ 10$54.55+0.87%
- BMRNBUYBioMarin Pharmaceutical Inc.$12.6BBULLQ 12$65.07-2.44%
- MDGLSELLMadrigal Pharmaceuticals, Inc.$11.8BRECOVERYQ 16$511.97-0.92%
- IONSBUYIonis Pharmaceuticals, Inc.$10.3BRECOVERYQ 9$62.04+3.85%
- SMMTSELLSummit Therapeutics Inc.$10.2BCRISISQ 16$12.73-3.27%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 26
- VALUE
- 16
- GROWTH
- 44
- GARP
- 15
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC114.3%
REV YoY-
ROE190.4%
EPS YoY-
ROA33.1%
GROSS90
OP10
NET72
[VALUATION]
P/E TTM17.84
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B9.67
P/FCF-
EV/EBITDA166.97
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E31.33
ALTMAN Z-
CURR RATIO2.99
ND/EBITDA-
BETA0.38
